Login / Signup

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.

Denise A YardleyEdward R ArrowsmithBrooke R DanielJanice EakleAdam BrufskyDavid R DrosickFred KudrikLinda D BossermanMark R KeatonSharon A GobleJeffrey A BubisVictor M PriegoKelly PendergrassYvonne ManaloMartin BuryDonald S GravenorGladys I RodriguezRoger C InhornRobyn R YoungWilliam N HarwinCaryn SilverJohn D HainsworthHoward A Burris
Published in: Breast cancer research and treatment (2017)
Clinical Trials.gov Identifier, NCT00789581.
Keyphrases
  • phase iii
  • clinical trial
  • early stage
  • open label
  • phase ii
  • double blind
  • drug delivery
  • low dose
  • high dose
  • placebo controlled
  • lymph node
  • neoadjuvant chemotherapy